Med. praxi. 2022;19(3):211-214 | DOI: 10.36290/med.2022.034

Tularemia: A series of three case reports

MUDr. Viktor Klementa, prof. MUDr. David Karásek, Ph.D., MUDr. Ester Kurašová
III. interní klinika - nefrologická, revmatologická a endokrinologická LF UP a FN Olomouc

Tularemia is a rare but potentially fatal infectious disease that can occur in wild and domestic animals, mainly rodents, and is also transmissible to humans. This disease should be considered in the differential diagnosis of acute febrile illness, especially when risk factors such as contact with wild mammals or exposure to blood-sucking arthropods are present. The clinical picture, diagnosis, and treatment of tularemia are described in the text below. Following are three case reports encountered during clinical practice in a general internal medicine department.

Keywords: tularemia, infection, zoonosis, antibiotics.

Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klementa V, Karásek D, Kurašová E. Tularemia: A series of three case reports. Med. praxi. 2022;19(3):211-214. doi: 10.36290/med.2022.034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Auwaerter PG, Penn RL. Francisella tularensis (Tularemia). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th ed, Bennet JE, Dolin R, Blaser MJ (Eds), Elsevier, Philadelphia; 2015. p. 2759.
    2. Evans ME, Gregory DW, Schaffner W, et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore). 1985;64:251. Go to original source... Go to PubMed...
    3. Eliasson H, Bäck E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect, DiS. 2007;39:880. Go to original source... Go to PubMed...
    4. Polat M, Karapinar T, Sirmatel F. Dermatological aspects of tularaemia: a study of 168 cases. Clin Exp Dermatol. 2018;43:770. Go to original source... Go to PubMed...
    5. Penn RL. Tularemia: Clinical manifestations, diagnosis, treatment, and prevention 2020; DOI: https://www.uptodate.com/contents/tularemia­‑clinical­‑manifestations­‑diagnosis­‑treatment­‑and­‑prevention?csi=19373312-8693-4d4c­‑b928-436ac157da72 & source=contentShare.
    6. Peterson JM, Schriefer ME. Francisella. In: Manual of Clinical Microbiology, 11th ed, Jorgensen J, Pfaller M, Carroll K, et al (Eds), American Society for Microbiology Press, Washington, DC; 2015. p. 851 Go to original source...
    7. Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci. 2007;1105:378. Go to original source... Go to PubMed...
    8. Thomas LD, Schaffner W. Tularemia pneumonia. Infect Dis Clin North Am. 2010;24:43. Go to original source... Go to PubMed...
    9. Scofield RH, Lopez EJ, McNabb SJ. Tularemia pneumonia in Oklahoma, 1982-1987. J Okla State Med Assoc. 1992;85:165. Go to PubMed...
    10. Sutera V, Hoarau G, Renesto P, et al. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure. Int J Antimicrob Agents. 2017;50:377. Go to original source... Go to PubMed...
    11. Cross JT, Jacobs RF. Tularemia: treatment failures with outpatient use of ceftriaxone. Clin Infect, DiS. 1993;17:976. Go to original source... Go to PubMed...
    12. Meric M, Willke A, Finke EJ, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS. 2008;116:66. Go to original source... Go to PubMed...
    13. Eliasson H, Broman T, Forsman M, Bäck E. Tularemia: current epidemiology and disease management. Infect Dis Clin North Am. 2006;20:289. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.